RECURRENT PERITONEAL CARCINOMA
Clinical trials for RECURRENT PERITONEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PERITONEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted therapy shows promise for Tough-to-Treat ovarian cancer
Disease control OngoingThis study tests a drug called mirvetuximab soravtansine in people with a specific type of recurrent ovarian cancer that has high levels of a protein called folate receptor alpha. The drug delivers chemotherapy directly to cancer cells to try to slow or stop the cancer from growi…
Matched conditions: RECURRENT PERITONEAL CARCINOMA
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New antibody combo shows promise for tough ovarian cancer
Disease control OngoingThis trial tests a new drug combination for women with recurrent ovarian cancer that has come back after initial treatment. The study includes 54 participants and uses an antibody called oregovomab along with standard chemotherapy and bevacizumab. The goal is to see if this mix i…
Matched conditions: RECURRENT PERITONEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC